Supplemental Materials for "A Phase 2a Trial of Brepocitinib for Cicatricial Alopecia"
Published: 15 October 2024| Version 1 | DOI: 10.17632/nsjbw2d8r2.1
Contributors:
, , , , , , , , , , , , , , , , , Description
Supplemental material for "A phase 2a trial of brepocitinib for cicatricial alopecia"
Files
Institutions
- Icahn School of Medicine at Mount SinaiNY, New York
Categories
Clinical Trial, Fibrosis, Alopecia, Janus Kinase
Funders
- Pfizer (United States)New York, United States